Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för G-15. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2024-07-17

Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptor.

Zhu Z, Nie X, Deng L, Ding J, Chen J, Zhu J, Yin X, Guo B, Zhang F.

Anticancer Drugs · research support, non-u.s. gov't; journal article · DOI 10.1097/cad.0000000000001640

Bibliografisk träff 2024-07-02

G-Protein Coupled Receptor 1 Is Involved in Tetrachlorobisphenol A-Induced Inflammatory Response in Jurkat Cells.

Lu X, Yu M, Yang Y, Zhang X, Chen T, Lei B.

Toxics · research-article; journal article · DOI 10.3390/toxics12070485

Bibliografisk träff 2024-04-26

17β-Estradiol (E2) Activates Matrix Mineralization through Genomic/Nongenomic Pathways in MC3T3-E1 Cells.

Suzuki H, Fujiwara Y, Ariyani W, Amano I, Ishii S, Ninomiya AK, Sato S, Takaoka A, Koibuchi N.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms25094727

Bibliografisk träff 2018-09-04

A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth.

O'Dea A, Sondergard C, Sweeney P, Arnatt CK.

ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/acsmedchemlett.8b00212

Bibliografisk träff 2018-04-20

Intracranial administration of the G-protein coupled estrogen receptor 1 antagonist, G-15, selectively affects dimorphic characteristics of the song system in zebra finches (Taeniopygia guttata).

Tehrani MA, Veney SL.

Dev Neurobiol · journal article · DOI 10.1002/dneu.22599

Bibliografisk träff 2017-08-25

G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.

Liu C, Liao Y, Fan S, Fu X, Xiong J, Zhou S, Zou M, Wang J.

Oncol Res · research-article; journal article · DOI 10.3727/096504017x15035795904677

Bibliografisk träff 2017-06-02

Baicalein, unlike 4-hydroxytamoxifen but similar to G15, suppresses 17β-estradiol-induced cell invasion, and matrix metalloproteinase-9 expression and activation in MCF-7 human breast cancer cells.

Chen Y, Hong DY, Wang J, Ling-Hu J, Zhang YY, Pan D, Xu YN, Tao L, Luo H, Shen XC.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2017.6298

Bibliografisk träff 2015-05-15

G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.

Liu Y, Du FY, Chen W, Fu PF, Yao MY, Zheng SS.

Am J Transl Res · research-article; journal article

Bibliografisk träff 2013-08-06

GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway.

Jang EJ, Seok YM, Arterburn JB, Olatunji LA, Kim IK.

J Pharm Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1111/jphp.12113

Bibliografisk träff 2011-07-14

Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity.

Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER.

J Steroid Biochem Mol Biol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.jsbmb.2011.07.002

Bibliografisk träff 2010-02-01

Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30.

Ramesh C, Nayak TK, Burai R, Dennis MK, Hathaway HJ, Sklar LA, Prossnitz ER, Arterburn JB.

J Med Chem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm9011802

Bibliografisk träff 2009-06-01

In vivo effects of a GPR30 antagonist.

Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER.

Nat Chem Biol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/nchembio.168